The estimated Net Worth of Joe Annoni is at least $125 dollars as of 22 February 2023. Joe Annoni owns over 625 units of Athenex Inc stock worth over $125 and over the last 3 years Joe sold ATNX stock worth over $0.
Joe has made over 1 trades of the Athenex Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Joe exercised 625 units of ATNX stock worth $125 on 22 February 2023.
The largest trade Joe's ever made was exercising 625 units of Athenex Inc stock on 22 February 2023 worth over $125. On average, Joe trades about 208 units every 0 days since 2022. As of 22 February 2023 Joe still owns at least 625 units of Athenex Inc stock.
You can see the complete history of Joe Annoni stock trades at the bottom of the page.
Joe's mailing address filed with the SEC is C/O ATHENEX, INC., 1001 MAIN STREET, SUITE 600, BUFFALO, NY, 14203.
Over the last 7 years, insiders at Athenex Inc have traded over $33,215,399 worth of Athenex Inc stock and bought 5,920,005 units worth $73,651,360 . The most active insiders traders include Advisors Llcperceptive Life..., Song Yi Zhang, eSong Yi Mandra Medical Ltd .... On average, Athenex Inc executives and independent directors trade stock every 12 days with the average trade being worth of $10,843. The most recent stock trade was executed by Joe Annoni on 22 February 2023, trading 625 units of ATNX stock currently worth $125.
athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. the company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients. our business includes medical technology innovation centers and a unique manufacturing supply chain across both china and north america. through the connected innovation and manufacturing supply chain presence, we can identify, develop and deliver proprietary medical technology across continents and multiple regulatory environments.
Athenex Inc executives and other stock owners filed with the SEC include: